[Elsevier] Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J)

rdoca Post time 1 hour(s) ago | Show all posts |Read mode
Reward40points

10.1016/S2213-8587(26)00138-5

The Lancet Diabetes & Endocrinology
Available online 17 August 2026

Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial

Prof Daisuke Yabe, Toshihiko Shiraiwa


Reply

Use magic Donate Report

All Reply1 Show all posts
samurai3005 Post time Half hour(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    155831


Return to the list